This is a Request for Information (RFI) and market research notice for non-invasive urine testing for prostate cancer, which may or may not lead to a future solicitation. The required test must provide a risk score for aggressive prostate cancer using RNA markers without incorporating PSA levels or a prior digital rectal exam. Services are intended for multiple VA facilities located in Colorado, Montana, Oklahoma, and Utah. The vendor must ship test kits directly to patients or designated laboratories with prepaid return labels. No budget, specific performance timelines, or bid deadlines are included in this RFI description.